Human Longevity
Coverage of Human Longevity in the Nexus archive.
- My father died of cancer at 72. A $12,000 longevity exam at a Silicon Valley clinic found both good and bad news in my DNA.
The author underwent a $12,000 longevity test at Human Longevity in Silicon Valley to assess cancer and other health risks after their father died of pancreatic cancer. The results showed a 99% chance of being cancer-free but revealed elevated risks for neurological conditions. The tests included genomic sequencing, blood work, and MRI scans.
- Insilico teams up with US firm to build AI models predicting disease decades ahead
Insilico Medicine, a Hong Kong-listed AI drug-discovery company, has partnered with US-based Human Longevity to develop large-scale AI foundation models capable of predicting diseases like cancer decades before symptoms appear. The collaboration aims to leverage advancements in AI and the growing $5.3 trillion global longevity market driven by aging populations.
- Insilico teams up with US firm to build AI models predicting disease decades ahead
Insilico Medicine, a Hong Kong-listed AI drug-discovery company, has partnered with US-based Human Longevity to develop large-scale AI foundation models capable of predicting diseases like cancer decades before symptoms appear. The collaboration aims to leverage the growing global longevity market, valued at $5.3 trillion.